RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | Chemically-Induced Disorders |
|
Accession: | DOID:9008261
|
browse the term
|
Definition: | Disorders caused by the intentional or unintentional ingestion or exposure to chemical substances such as PHARMACEUTICAL PREPARATIONS; NOXAE; and PESTICIDES. |
Synonyms: | exact_synonym: | Chemically-Induced Disorder |
| primary_id: | MESH:D064419; RDO:0015820 |
| subset: | RGD_JBrowse_slim |
For additional species annotation, visit the
Alliance of Genome Resources.
|
|
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
ISO |
ClinVar Annotator: match by term: Alcohol sensitivity, acute | ClinVar Annotator: match by term: Susceptibility to hangover CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD |
PMID:2987944 PMID:4065146 PMID:6650498 PMID:7180842 PMID:7593603 PMID:8903321 PMID:10627091 PMID:10780266 PMID:15654505 PMID:15902904 PMID:16046871 PMID:16440063 PMID:16679777 PMID:17885622 PMID:18056758 PMID:20010786 PMID:22992668 PMID:25741868 PMID:28492532 PMID:33355142 More...
|
|
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
|
G |
Adh1 |
alcohol dehydrogenase 1C (class I), gamma polypeptide |
|
ISO |
ClinVar Annotator: match by term: Alcohol dependence |
ClinVar |
PMID:3397059 PMID:3758060 PMID:10090900 PMID:15863807 PMID:17718394 PMID:17923853 More...
|
|
NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
ISO |
ClinVar Annotator: match by term: Alcohol dependence |
ClinVar |
PMID:2987944 PMID:4065146 PMID:6650498 PMID:7180842 PMID:7593603 PMID:8903321 PMID:10627091 PMID:10780266 PMID:15654505 PMID:15902904 PMID:16046871 PMID:16440063 PMID:16679777 PMID:17885622 PMID:18056758 PMID:20010786 PMID:22992668 PMID:33355142 More...
|
|
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Avpr1b |
arginine vasopressin receptor 1B |
|
IEP |
|
RGD |
PMID:21309953 |
RGD:14700679 |
NCBI chr13:43,046,960...43,057,110
Ensembl chr13:43,046,267...43,057,792
|
|
G |
Cacna1c |
calcium voltage-gated channel subunit alpha1 C |
|
IEP |
mRNA, protein:increased expression:amygdala, hippocampus (rat) protein:increased expression:inferior colliculus (human) |
RGD |
PMID:27905406 PMID:25556199 |
RGD:152985537, RGD:152985539 |
NCBI chr 4:151,764,138...152,379,454
Ensembl chr 4:151,764,138...152,379,648
|
|
G |
Gabra2 |
gamma-aminobutyric acid type A receptor subunit alpha 2 |
|
ISO |
ClinVar Annotator: match by term: Alcohol dependence |
ClinVar |
|
|
NCBI chr14:37,096,995...37,230,030
Ensembl chr14:37,097,279...37,228,944
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
IEP |
protein:increased activity:plasma,liver,intestine: |
RGD |
PMID:6113606 |
RGD:14701046 |
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
|
ISO |
|
RGD |
PMID:29582627 |
RGD:14700988 |
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Lama2 |
laminin subunit alpha 2 |
|
ISO |
ClinVar Annotator: match by term: Alcohol dependence |
ClinVar |
PMID:25741868 |
|
NCBI chr 1:17,672,675...18,320,641
Ensembl chr 1:17,672,536...18,320,530
|
|
G |
Lep |
leptin |
|
IDA IEP |
DNA:hypermethylation:promoter protein:decreased expression:serum |
RGD |
PMID:29912265 PMID:29912265 |
RGD:21201248, RGD:21201248 |
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Slc29a1 |
solute carrier family 29 member 1 |
|
ISS |
OMIM:103780 |
MouseDO |
|
|
NCBI chr 9:15,399,661...15,414,203
Ensembl chr 9:15,399,612...15,414,203
|
|
|
G |
Atp2a1 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 |
|
IEP |
|
RGD |
PMID:14506614 |
RGD:1581765 |
NCBI chr 1:181,026,606...181,044,859
Ensembl chr 1:181,026,608...181,044,838
|
|
|
G |
Adh1 |
alcohol dehydrogenase 1C (class I), gamma polypeptide |
|
ISO |
ClinVar Annotator: match by term: Alcohol dependence CTD Direct Evidence: marker/mechanism |
ClinVar CTD OMIM |
PMID:3397059 PMID:3758060 PMID:10090900 PMID:15863807 PMID:16404797 PMID:17718394 PMID:17923853 More...
|
|
NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892
|
|
G |
Adh5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
|
IMP |
|
RGD |
PMID:8462548 |
RGD:5129091 |
NCBI chr 2:226,975,184...226,987,591
Ensembl chr 2:226,947,466...226,987,591
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
ISO |
ClinVar Annotator: match by term: Alcohol dependence CTD Direct Evidence: marker/mechanism |
ClinVar CTD RGD |
PMID:2987944 PMID:4065146 PMID:6650498 PMID:7180842 PMID:7593603 PMID:8903321 PMID:10627091 PMID:10780266 PMID:15654505 PMID:15902904 PMID:16046871 PMID:16404797 PMID:16440063 PMID:16679777 PMID:17590986 PMID:17885622 PMID:18056758 PMID:20010786 PMID:22992668 PMID:33355142 PMID:10780266 More...
|
RGD:734551 |
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
|
IEP |
protein:decreased expression:plasma |
RGD |
PMID:32135570 |
RGD:35673317 |
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
|
ISO |
mRNA:increased expression:prefrontal cortex |
RGD |
PMID:28714806 |
RGD:18337277 |
NCBI chr 5:150,674,819...150,676,600
Ensembl chr 5:150,673,507...150,676,600
|
|
G |
Cckar |
cholecystokinin A receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9922984 |
|
NCBI chr14:57,292,397...57,300,747
Ensembl chr14:57,292,397...57,300,747
|
|
G |
Cdk20 |
cyclin-dependent kinase 20 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18438686 |
|
NCBI chr17:701,122...707,869
Ensembl chr17:701,124...707,826
|
|
G |
Chrna3 |
cholinergic receptor nicotinic alpha 3 subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18414406 |
|
NCBI chr 8:55,401,981...55,415,012
Ensembl chr 8:55,401,702...55,415,165
|
|
G |
Chrna5 |
cholinergic receptor nicotinic alpha 5 subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18414406 |
|
NCBI chr 8:55,369,794...55,398,526
Ensembl chr 8:55,369,794...55,398,146
|
|
G |
Comt |
catechol-O-methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10395222 |
|
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Crh |
corticotropin releasing hormone |
|
IEP |
mRNA:increased expression:central amygdaloid nucleus (rat) |
RGD |
PMID:20060104 |
RGD:5508173 |
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
|
|
G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
|
ISO |
|
RGD |
PMID:11988580 |
RGD:734822 |
NCBI chr10:89,040,203...89,083,481
Ensembl chr10:89,040,203...89,083,481
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
ISO IEP |
CTD Direct Evidence: marker/mechanism protein:increased expression:plasma, extracellular exosome |
CTD RGD |
PMID:20843640 PMID:23819932 PMID:29404485 PMID:29404485 |
RGD:14700915, RGD:14700911, RGD:14700911 |
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Dbh |
dopamine beta-hydroxylase |
no_association |
ISO |
DNA:polymorphism:5' utr:g.-1021C>T (human) DNA:polymorphism:cds:g.444G>A (human) |
RGD |
PMID:16133787 PMID:16252068 |
RGD:1625572, RGD:1625571 |
NCBI chr 3:10,488,260...10,505,245
Ensembl chr 3:10,488,260...10,505,248
|
|
G |
Drd2 |
dopamine receptor D2 |
|
IEA |
|
GAD |
PMID:15118671 |
RGD:1331525 |
NCBI chr 8:49,708,903...49,772,888
Ensembl chr 8:49,708,927...49,772,875
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
|
IEP |
|
RGD |
PMID:23095216 |
RGD:10045658 |
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8590623 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Gabbr1 |
gamma-aminobutyric acid type B receptor subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22253714 |
|
NCBI chr20:1,464,534...1,494,114
Ensembl chr20:1,464,534...1,493,994
|
|
G |
Gabra2 |
gamma-aminobutyric acid type A receptor subunit alpha 2 |
susceptibility |
ISO |
DNA:SNPs:multiple: ClinVar Annotator: match by term: Alcohol dependence CTD Direct Evidence: marker/mechanism |
ClinVar CTD OMIM RGD |
PMID:22253714 PMID:15024690 |
RGD:6480257 |
NCBI chr14:37,096,995...37,230,030
Ensembl chr14:37,097,279...37,228,944
|
|
G |
Gabrg2 |
gamma-aminobutyric acid type A receptor subunit gamma 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22253714 |
|
NCBI chr10:26,376,805...26,463,680
Ensembl chr10:26,374,694...26,464,346
|
|
G |
Gata4 |
GATA binding protein 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20585342 |
|
NCBI chr15:37,459,601...37,531,291
Ensembl chr15:37,459,601...37,505,636
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12747453 |
|
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
|
|
G |
Ghsr |
growth hormone secretagogue receptor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:23977009 |
|
NCBI chr 2:110,268,489...110,271,865
Ensembl chr 2:110,268,489...110,271,865
|
|
G |
Gphn |
gephyrin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22253714 |
|
NCBI chr 6:96,954,365...97,483,617
Ensembl chr 6:96,892,148...97,483,612
|
|
G |
Grin1 |
glutamate ionotropic receptor NMDA type subunit 1 |
|
ISO |
|
RGD |
PMID:14573320 |
RGD:1642372 |
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
|
|
G |
Grin2b |
glutamate ionotropic receptor NMDA type subunit 2B |
|
ISO |
|
RGD |
PMID:14573320 PMID:16911840 |
RGD:1642372, RGD:1642200 |
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
|
|
G |
Hdac2 |
histone deacetylase 2 |
|
IMP |
|
RGD |
PMID:23485013 |
RGD:9590265 |
NCBI chr20:40,548,250...40,571,609
Ensembl chr20:40,548,250...40,571,609
|
|
G |
Htr2a |
5-hydroxytryptamine receptor 2A |
|
ISO |
|
OMIM |
|
|
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
|
|
G |
Htr3b |
5-hydroxytryptamine receptor 3B |
susceptibility |
ISO |
DNA:SNP:cds:rs1176744(human) |
RGD |
PMID:20838391 |
RGD:6480660 |
NCBI chr 8:49,279,291...49,308,444
Ensembl chr 8:49,279,173...49,308,444
|
|
G |
Htr7 |
5-hydroxytryptamine receptor 7 |
|
ISO |
DNA:SNP:intron: (rs7916403) (human) |
RGD |
PMID:21184583 |
RGD:150429835 |
NCBI chr 1:233,636,442...233,761,063
Ensembl chr 1:233,636,452...233,760,626
|
|
G |
Kcnj6 |
potassium inwardly-rectifying channel, subfamily J, member 6 |
|
ISO |
DNA:SNP:promoter:rs2836016 (human) |
RGD |
PMID:21307845 |
RGD:6483053 |
NCBI chr11:34,061,705...34,309,128
Ensembl chr11:34,061,708...34,308,758
|
|
G |
Lama2 |
laminin subunit alpha 2 |
|
ISO |
ClinVar Annotator: match by term: Alcohol dependence |
ClinVar |
PMID:25741868 |
|
NCBI chr 1:17,672,675...18,320,641
Ensembl chr 1:17,672,536...18,320,530
|
|
G |
Lhb |
luteinizing hormone subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8590623 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Maoa |
monoamine oxidase A |
susceptibility |
ISO |
|
RGD |
PMID:15900229 |
RGD:1600720 |
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
|
|
G |
Mcm5 |
minichromosome maintenance complex component 5 |
|
IEP |
|
RGD |
PMID:23095216 |
RGD:10045658 |
NCBI chr19:13,483,030...13,504,389
Ensembl chr19:13,483,066...13,504,389
|
|
G |
Mir191 |
microRNA 191 |
onset |
IEP |
|
RGD |
PMID:32135570 |
RGD:35673317 |
NCBI chr 8:109,264,098...109,264,188
|
|
G |
Mir195 |
microRNA 195 |
onset |
IEP |
|
RGD |
PMID:32135570 |
RGD:35673317 |
NCBI chr10:54,951,838...54,951,924
Ensembl chr10:54,951,838...54,951,924
|
|
G |
Mir206 |
microRNA 206 |
onset |
IEP |
|
RGD |
PMID:32135570 |
RGD:35673317 |
NCBI chr 9:23,094,249...23,094,332
Ensembl chr 9:23,094,249...23,094,332
|
|
G |
Mir30a |
microRNA 30a |
onset |
IEP |
|
RGD |
PMID:32135570 |
RGD:35673317 |
NCBI chr 9:25,737,600...25,737,670
Ensembl chr 9:25,737,600...25,737,670
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
IEP |
|
RGD |
PMID:24966898 |
RGD:13207311 |
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
IEP |
|
RGD |
PMID:24966898 |
RGD:13207311 |
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Npy |
neuropeptide Y |
|
IAGP ISO |
DNA:deletion:intron:g.4666_4674del (rat) CTD Direct Evidence: marker/mechanism DNA:missense mutation: :p.L7P (human) |
CTD RGD |
PMID:17572454 PMID:15749341 PMID:12215082 |
RGD:1357412, RGD:10430830 |
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
|
|
G |
Npy2r |
neuropeptide Y receptor Y2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18828811 |
|
NCBI chr 2:167,901,999...167,912,165
Ensembl chr 2:167,903,879...167,905,024
|
|
G |
Oprl1 |
opioid related nociceptin receptor 1 |
|
IMP |
|
RGD |
PMID:11814626 |
RGD:9835016 |
NCBI chr 3:168,831,934...168,839,920
Ensembl chr 3:168,834,003...168,839,920
|
|
G |
Oprm1 |
opioid receptor, mu 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12815747 |
|
NCBI chr 1:43,160,057...43,413,409
Ensembl chr 1:43,160,057...43,413,409
|
|
G |
Pde4b |
phosphodiesterase 4B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18438686 |
|
NCBI chr 5:116,799,827...117,367,707
Ensembl chr 5:116,799,971...117,367,696
|
|
G |
Pdyn |
prodynorphin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17559549 PMID:18923396 |
|
NCBI chr 3:116,900,990...116,913,334
Ensembl chr 3:116,900,992...116,913,334
|
|
G |
Penk |
proenkephalin |
|
IEP |
mRNA:increased expression:frontal lobe: |
RGD |
PMID:22703995 |
RGD:10003152 |
NCBI chr 5:17,183,799...17,189,160
Ensembl chr 5:17,183,806...17,189,129
|
|
G |
Rpl18a |
ribosomal protein L18A |
|
IEP |
mRNA:decreased expression:parietal cortex |
RGD |
PMID:11244494 |
RGD:11038708 |
NCBI chr16:18,542,572...18,544,578
Ensembl chr16:18,542,566...18,545,546
|
|
G |
Shbg |
sex hormone binding globulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8590623 |
|
NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27219321 |
|
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
susceptibility |
ISO |
protein:decreased activity: : CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:15520362 PMID:17000009 PMID:20838391 |
RGD:6480660 |
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
|
|
G |
Snca |
synuclein alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18055133 |
|
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
|
|
G |
Spi1 |
Spi-1 proto-oncogene |
treatment |
IEP IDA |
protein:decreased expression:alveolar macrophage |
RGD |
PMID:16272341 PMID:21447000 |
RGD:9586723, RGD:9586725 |
NCBI chr 3:77,059,744...77,093,730
Ensembl chr 3:77,073,012...77,092,393
|
|
G |
St6gal1 |
ST6 beta-galactoside alpha-2,6-sialyltransferase 1 |
severity |
ISO |
mRNA,protein:decreased expression:liver: |
RGD |
PMID:17697868 |
RGD:10043133 |
NCBI chr11:77,526,837...77,653,474
Ensembl chr11:77,526,837...77,653,310
|
|
G |
Tacr1 |
tachykinin receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19204064 |
|
NCBI chr 4:114,920,844...115,089,733
Ensembl chr 4:114,920,844...115,089,733
|
|
G |
Tacr3 |
tachykinin receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18422838 |
|
NCBI chr 2:223,266,536...223,363,791
Ensembl chr 2:223,266,536...223,363,791
|
|
G |
Tas2r118 |
taste receptor, type 2, member 118 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Alcohol dependence, susceptibility to |
CTD OMIM ClinVar |
PMID:9603606 PMID:10923994 PMID:16051168 PMID:16385453 PMID:17250611 PMID:24177185 More...
|
|
NCBI chr 4:52,449,208...52,450,107
Ensembl chr 4:52,449,208...52,450,107
|
|
G |
Tas2r138 |
taste receptor, type 2, member 138 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17250611 |
|
NCBI chr 4:69,428,344...69,429,339
Ensembl chr 4:69,428,344...69,429,339
|
|
G |
Tbx19 |
T-box transcription factor 19 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18438686 |
|
NCBI chr13:77,450,848...77,484,475
Ensembl chr13:77,450,849...77,504,163
|
|
G |
Tf |
transferrin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11000917 PMID:21792595 |
|
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
|
|
G |
Tph1 |
tryptophan hydroxylase 1 |
|
ISO |
|
RGD |
PMID:15654285 |
RGD:1580464 |
NCBI chr 1:97,157,375...97,178,415
Ensembl chr 1:97,157,409...97,178,344
|
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
|
ISO |
|
RGD |
PMID:11841893 |
RGD:1626329 |
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
|
RGD |
PMID:16318954 |
RGD:5688289 |
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27219321 |
|
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
|
|
|
G |
Cacna1d |
calcium voltage-gated channel subunit alpha1 D |
susceptibility |
IEP |
mRNA, protein:increased expression:inferior colliculus (rat) |
RGD |
PMID:25556199 |
RGD:152985539 |
NCBI chr16:5,227,157...5,521,163
Ensembl chr16:5,228,306...5,668,215
|
|
G |
Slc29a1 |
solute carrier family 29 member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21283641 |
|
NCBI chr 9:15,399,661...15,414,203
Ensembl chr 9:15,399,612...15,414,203
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27219321 |
|
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
|
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
|
IEP |
protein:increased expression:cortex, hippocampus (rat) |
RGD |
PMID:18585922 |
RGD:2313030 |
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
|
|
G |
Cirbp |
cold inducible RNA binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24223948 |
|
NCBI chr 7:9,533,857...9,538,899
Ensembl chr 7:9,424,178...9,538,818
|
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26711020 |
|
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Foxo4 |
forkhead box O4 |
|
IEP |
protein:increased phosphorylation:small intestine: |
RGD |
PMID:23292333 |
RGD:10402360 |
NCBI chr X:66,385,241...66,392,115
Ensembl chr X:66,385,558...66,392,115
|
|
G |
Gsr |
glutathione-disulfide reductase |
treatment |
IEP |
|
RGD |
PMID:24972622 |
RGD:10401897 |
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Hectd4 |
HECT domain E3 ubiquitin protein ligase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35713687 |
|
NCBI chr12:35,182,165...35,330,935
Ensembl chr12:35,182,154...35,330,987
|
|
|
G |
Ppa2 |
inorganic pyrophosphatase 2 |
|
ISO |
ClinVar Annotator: match by term: Sudden cardiac failure, alcohol-induced |
OMIM ClinVar |
PMID:24033266 PMID:25741868 PMID:27523597 PMID:27523598 PMID:28492532 PMID:30384889 PMID:31705601 PMID:34400813 More...
|
|
NCBI chr 2:221,800,791...221,878,079
Ensembl chr 2:221,800,842...221,878,081
|
|
|
G |
Cartpt |
CART prepropeptide |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22823101 |
|
NCBI chr 2:31,255,098...31,257,452
Ensembl chr 2:31,255,098...31,290,713
|
|
G |
Casp8 |
caspase 8 |
treatment |
IEP |
|
RGD |
PMID:30118883 |
RGD:13782287 |
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
|
G |
Ace |
angiotensin I converting enzyme |
|
ISO |
|
GAD |
PMID:15118671 |
RGD:1331525 |
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Agt |
angiotensinogen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22497828 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Nos1 |
nitric oxide synthase 1 |
|
IEP |
protein:decreased expression:skeletal muscle, membrane |
RGD |
PMID:17607508 |
RGD:1642138 |
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
IEP |
protein:increased expression:heart myocardium |
RGD |
PMID:18783396 |
RGD:2301868 |
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Rxra |
retinoid X receptor alpha |
|
IEP |
|
RGD |
PMID:19791468 |
RGD:2317465 |
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
|
|
G |
Slc25a4 |
solute carrier family 25 member 4 |
|
IEP |
mRNA, protein:decreased expression:myocardium |
RGD |
PMID:21169901 |
RGD:9681464 |
NCBI chr16:46,072,935...46,076,730
Ensembl chr16:46,072,939...46,076,733
|
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:16115302 |
RGD:5686674 |
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adipor2 |
adiponectin receptor 2 |
treatment |
IEP ISO |
|
RGD |
PMID:26115886 PMID:18755807 PMID:27220557 PMID:22013387 |
RGD:25330099, RGD:25824943, RGD:25824939, RGD:25440493 |
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
severity treatment susceptibility |
IDA ISO |
human transgene in mouse model protein:altered processing:liver (mouse) DNA:missense mutation:cds:p.E504K (human) |
RGD |
PMID:17058263 PMID:25457208 PMID:29156373 PMID:29063269 |
RGD:1599041, RGD:15036811, RGD:15036805, RGD:14696776 |
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
ISO |
protein:increased expression:liver (human) |
RGD |
PMID:29307797 |
RGD:153297819 |
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
C1qc |
complement C1q C chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35789393 |
|
NCBI chr 5:149,127,424...149,130,732
Ensembl chr 5:149,127,415...149,131,017
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
treatment |
ISO |
|
RGD |
PMID:25557254 |
RGD:14995489 |
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
treatment |
ISO |
|
RGD |
PMID:25557254 |
RGD:14995489 |
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
disease_progression |
ISO |
|
RGD |
PMID:27859576 |
RGD:14401742 |
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
|
|
G |
Cd36 |
CD36 molecule |
|
ISO |
|
RGD |
PMID:24280415 |
RGD:11041117 |
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Crp |
C-reactive protein |
|
IEP |
protein:increased expression:serum: |
RGD |
PMID:21806828 |
RGD:9491781 |
NCBI chr13:85,131,635...85,175,179
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Ctsb |
cathepsin B |
|
IEP |
protein:increased activity:liver, cytosol (rat) |
RGD |
PMID:17850215 |
RGD:2315516 |
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:26428356 PMID:25583360 PMID:24064383 |
RGD:14700884, RGD:14700870 |
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
|
ISO |
|
RGD |
PMID:22905112 |
RGD:9588654 |
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
|
IEP |
mRNA:decreased expression:liver |
RGD |
PMID:19253830 |
RGD:11041633 |
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
|
|
G |
Ldlr |
low density lipoprotein receptor |
|
IEP |
protein:decreased expression: liver (rat) |
RGD |
PMID:20028367 |
RGD:21410185 |
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Mir155 |
microRNA 155 |
|
ISO |
|
RGD |
PMID:26867493 |
RGD:25671474 |
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
|
|
G |
Pemt |
phosphatidylethanolamine N-methyltransferase |
|
IEP |
|
RGD |
PMID:17156888 |
RGD:1642369 |
NCBI chr10:44,775,910...44,849,990
Ensembl chr10:44,775,911...44,850,013
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18703563 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Serpine1 |
serpin family E member 1 |
|
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:25561792 |
RGD:11075083 |
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Serpinf1 |
serpin family F member 1 |
|
IEP |
protein:decreased expression:liver |
RGD |
PMID:18996124 |
RGD:2312349 |
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
|
|
G |
Sod1 |
superoxide dismutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19951287 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
IEP |
|
RGD |
PMID:11477087 |
RGD:1625694 |
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
|
IEP |
|
RGD |
PMID:18296740 |
RGD:7207884 |
NCBI chr 9:49,472,660...49,588,540
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Tlr4 |
toll-like receptor 4 |
severity |
ISO |
|
RGD |
PMID:29884546 PMID:21463341 |
RGD:14697697, RGD:14700554 |
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
susceptibility treatment |
ISO IEP |
DNA:SNP:promoter:-238G>A (human) |
RGD |
PMID:9214463 PMID:20143470 |
RGD:14995434, RGD:38508901 |
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
treatment |
IEP |
|
RGD |
PMID:27939985 |
RGD:15036816 |
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Agt |
angiotensinogen |
|
ISO |
mRNA:decreased expression:liver |
RGD |
PMID:17258719 |
RGD:1601135 |
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Alb |
albumin |
severity |
ISO |
protein:increased expression, modification:urine |
RGD |
PMID:29369844 |
RGD:14694842 |
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
severity |
ISO |
RNA:increased expression:liver: |
RGD |
PMID:24429361 PMID:21826694 PMID:10446112 |
RGD:14975280, RGD:14995491, RGD:14995467 |
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
severity |
ISO |
|
RGD |
PMID:10446112 |
RGD:14995467 |
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:12586603 PMID:31258651 |
RGD:14995304 |
NCBI chr10:68,322,826...68,327,365
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
|
ISO |
|
RGD |
PMID:1670041 |
RGD:5688335 |
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
treatment |
IEP |
|
RGD |
PMID:27939985 |
RGD:15036816 |
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
treatment |
IEP |
|
RGD |
PMID:27939985 |
RGD:15036816 |
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
disease_progression severity |
ISO |
mRNA:increased expression:liver (mouse) mRNA:increased expression:liver (human) |
RGD |
PMID:33173221 PMID:33173221 |
RGD:151347691, RGD:151347691 |
NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468
|
|
G |
Fas |
Fas cell surface death receptor |
treatment |
IEP |
|
RGD |
PMID:27939985 |
RGD:15036816 |
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fgf19 |
fibroblast growth factor 19 |
treatment |
IEP |
|
RGD |
PMID:27939985 |
RGD:15036816 |
NCBI chr 1:200,056,656...200,059,944
Ensembl chr 1:200,056,644...200,060,287
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
severity |
ISO |
protein:increased expression:hepatocyte |
RGD |
PMID:1347281 |
RGD:14402038 |
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Il13 |
interleukin 13 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:16698589 |
RGD:1581860 |
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il18 |
interleukin 18 |
severity |
ISO |
associated alcoholic liver cirrhosis; protein:increased expression:plasma: |
RGD |
PMID:15566508 |
RGD:14696666 |
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Mir155 |
microRNA 155 |
|
IEP |
RNA:increased expression:liver |
RGD |
PMID:32317960 |
RGD:151347420 |
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
treatment |
IEP |
|
RGD |
PMID:27939985 |
RGD:15036816 |
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
treatment |
IEP |
|
RGD |
PMID:27939985 |
RGD:15036816 |
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
treatment |
IEP |
|
RGD |
PMID:27939985 |
RGD:15036816 |
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
treatment |
IEP |
|
RGD |
PMID:27939985 |
RGD:15036816 |
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
treatment |
IEP |
|
RGD |
PMID:27939985 |
RGD:15036816 |
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
treatment |
IEP |
|
RGD |
PMID:27939985 |
RGD:15036816 |
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Slc10a1 |
solute carrier family 10 member 1 |
treatment |
IEP |
|
RGD |
PMID:27939985 |
RGD:15036816 |
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
|
IEP |
mRNA:decreased expression:liver |
RGD |
PMID:32317960 |
RGD:151347420 |
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
treatment |
IEP |
|
RGD |
PMID:27939985 |
RGD:15036816 |
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Sts |
steroid sulfatase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26220752 |
|
NCBI chr X:42,225,131...42,233,403
Ensembl chr X:42,225,372...42,233,402
|
|
G |
Sult1e1 |
sulfotransferase family 1E member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26220752 |
|
NCBI chr14:20,422,324...20,439,562
Ensembl chr14:20,422,324...20,439,275
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:12586603 PMID:27939985 |
RGD:15036816 |
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Drd2 |
dopamine receptor D2 |
treatment |
IDA |
|
RGD |
PMID:28300818 |
RGD:13506954 |
NCBI chr 8:49,708,903...49,772,888
Ensembl chr 8:49,708,927...49,772,875
|
|
G |
Ifng |
interferon gamma |
treatment |
ISO |
|
RGD |
PMID:9514301 |
RGD:10755766 |
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Nps |
neuropeptide S |
|
IDA |
|
RGD |
PMID:19860802 |
RGD:9831199 |
NCBI chr 1:190,077,040...190,080,821
Ensembl chr 1:190,077,040...190,080,821
|
|
G |
Npsr1 |
neuropeptide S receptor 1 |
|
IEP |
mRNA:increased expression:brain |
RGD |
PMID:19860802 |
RGD:9831199 |
NCBI chr 8:22,606,946...22,831,558
Ensembl chr 8:22,606,946...22,831,558
|
|
G |
Per2 |
period circadian regulator 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15608650 |
|
NCBI chr 9:92,007,289...92,049,551
Ensembl chr 9:92,007,296...92,049,459
|
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
susceptibility |
ISO |
DNA:missense mutation:cds:p.E504K (human) DNA:missense mutation:cds: (rs671) (human) associated with alcohol dependence;DNA:missense mutation:exon 12:p.E487K (human) |
RGD |
PMID:29779728 PMID:23550892 PMID:11051375 |
RGD:14696777, RGD:15042864, RGD:15042858 |
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
|
ISO |
protein:decreased expression:brain |
RGD |
PMID:16205370 |
RGD:6483345 |
NCBI chr10:85,511,164...85,517,723
Ensembl chr10:85,511,160...85,517,720
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Crp |
C-reactive protein |
severity |
ISO |
|
RGD |
PMID:22441510 |
RGD:6482305 |
NCBI chr13:85,131,635...85,175,179
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20843640 PMID:29404441 |
RGD:14700873 |
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
severity |
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:33173221 |
RGD:151347691 |
NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468
|
|
G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
disease_progression ameliorates |
IEP IMP |
|
RGD |
PMID:21199726 PMID:23409069 |
RGD:150429766, RGD:150517731 |
NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
|
|
G |
Fabp2 |
fatty acid binding protein 2 |
onset |
ISO |
DNA:polymorphism:CDS:amino acid A54T, homozygosity of the T allele associated with later onset |
RGD |
PMID:16289894 PMID:16289894 |
RGD:1578455, RGD:1578455 |
NCBI chr 2:211,040,032...211,044,089
Ensembl chr 2:211,040,032...211,044,089
|
|
G |
Il18bp |
interleukin 18 binding protein |
|
ISO |
protein:increased expression:plasma: |
RGD |
PMID:15566508 |
RGD:14696666 |
NCBI chr 1:156,372,923...156,374,963
Ensembl chr 1:156,372,883...156,374,963
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Jak2 |
Janus kinase 2 |
|
ISO |
mRNA, protein:increased expression, increased tyrosine phosphorylation:liver |
RGD |
PMID:24619965 |
RGD:10403061 |
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Lep |
leptin |
|
IDA |
DNA:hypomethylation:promoter (human) |
RGD |
PMID:29912265 |
RGD:21201248 |
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Mboat7 |
membrane bound O-acyltransferase domain containing 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26482880 |
|
NCBI chr 1:65,525,206...65,539,538
Ensembl chr 1:65,525,213...65,539,538
|
|
G |
Mir122 |
microRNA 122 |
|
ISO |
miRNA:decreased expression:liver |
RGD |
PMID:28987423 |
RGD:14401600 |
NCBI chr18:58,758,703...58,758,787
|
|
G |
Mir141 |
microRNA 141 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr 4:157,523,239...157,523,332
Ensembl chr 4:157,523,239...157,523,332
|
|
G |
Mir17 |
microRNA 17 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr15:92,180,629...92,180,712
Ensembl chr15:92,180,629...92,180,712
|
|
G |
Mir193b |
microRNA 193b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr10:1,317,742...1,317,824
Ensembl chr10:1,317,742...1,317,824
|
|
G |
Mir423 |
microRNA 423 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr10:61,914,142...61,914,220
Ensembl chr10:61,914,133...61,914,226
|
|
G |
Mir484 |
microRNA 484 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr10:887,684...887,760
Ensembl chr10:887,684...887,760
|
|
G |
Mir532 |
microRNA 532 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr X:15,247,315...15,247,393
Ensembl chr X:15,247,315...15,247,393
|
|
G |
Mir93 |
microRNA 93 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr12:17,043,135...17,043,221
Ensembl chr12:17,043,135...17,043,221
|
|
G |
Mmp13 |
matrix metallopeptidase 13 |
|
IEP |
|
RGD |
PMID:16286264 |
RGD:10043176 |
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mpo |
myeloperoxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19731237 PMID:23274713 |
|
NCBI chr10:72,594,458...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
susceptibility |
ISO |
DNA:SNP: :677C>T(human) |
RGD |
PMID:25987440 |
RGD:14696749 |
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
|
|
G |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
|
ISO |
|
RGD |
PMID:24497272 |
RGD:10448995 |
NCBI chr10:83,728,348...83,735,562
Ensembl chr10:83,728,318...83,735,705
|
|
G |
Plau |
plasminogen activator, urokinase |
|
IDA |
|
RGD |
PMID:19615318 |
RGD:7241800 |
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Pnpla3 |
patatin-like phospholipase domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19946271 PMID:26482880 |
|
NCBI chr 7:115,293,538...115,314,077
Ensembl chr 7:115,293,538...115,314,077
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Serpine1 |
serpin family E member 1 |
susceptibility |
ISO |
DNA:polymorphism:promoter: |
RGD |
PMID:25987440 |
RGD:14696749 |
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Serpinf1 |
serpin family F member 1 |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:27748324 |
RGD:27226704 |
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
|
|
G |
Smad3 |
SMAD family member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
|
|
G |
Sod2 |
superoxide dismutase 2 |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism DNA:SNP: : 47T>C(human) |
CTD RGD |
PMID:19731237 PMID:26873981 |
RGD:11060603 |
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tlr9 |
toll-like receptor 9 |
|
ISO |
protein:increased expression:blood, neutrophil (human) |
RGD |
PMID:18433921 |
RGD:5130706 |
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
|
|
G |
Tm6sf2 |
transmembrane 6 superfamily member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26482880 |
|
NCBI chr16:19,344,218...19,351,431
Ensembl chr16:19,344,222...19,351,431
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Ace |
angiotensin I converting enzyme |
severity treatment |
ISO |
protein:increased activity:serum (human) |
RGD |
PMID:3028446 PMID:28691216 |
RGD:19165343, RGD:40400719 |
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Adipor2 |
adiponectin receptor 2 |
treatment |
IEP |
|
RGD |
PMID:24797033 |
RGD:25824940 |
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
susceptibility severity |
ISO |
DNA:missense mutation:cds, exon 12:p.E487K (human) DNA:polymorphism:exon 12: (human) DNA:deletion:cds: (mouse) |
RGD |
PMID:1916152 PMID:12198368 PMID:26173414 PMID:3189338 |
RGD:14696699, RGD:14981580, RGD:11076022, RGD:14696790 |
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Angpt2 |
angiopoietin 2 |
severity |
ISO |
|
RGD |
PMID:24959006 |
RGD:15014784 |
NCBI chr16:71,088,364...71,138,805
Ensembl chr16:71,088,364...71,138,804
|
|
G |
C6 |
complement C6 |
resistance |
IAGP |
|
RGD |
PMID:15351314 |
RGD:1600673 |
NCBI chr 2:53,846,027...53,921,279
Ensembl chr 2:53,851,985...53,921,275
|
|
G |
Cav1 |
caveolin 1 |
treatment |
IEP |
|
RGD |
PMID:23764359 |
RGD:8662277 |
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
|
|
G |
Cd27 |
CD27 molecule |
|
IEP |
|
RGD |
PMID:16698589 |
RGD:1581860 |
NCBI chr 4:158,030,700...158,035,862
Ensembl chr 4:158,030,703...158,035,592
|
|
G |
Cd59 |
CD59 molecule |
|
IEP |
protein:decreased expression:liver |
RGD |
PMID:12483994 |
RGD:1600486 |
NCBI chr 3:90,459,085...90,477,571
Ensembl chr 3:90,459,162...90,478,847
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
susceptibility |
ISO |
DNA:SNP::-318 T>C(rs5742909)(human) |
RGD |
PMID:15208156 |
RGD:14398728 |
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:10498645 |
RGD:5135271 |
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:10498645 |
RGD:5135271 |
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl6 |
C-X-C motif chemokine ligand 6 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:10498645 |
RGD:5135271 |
NCBI chr14:17,310,089...17,312,303
Ensembl chr14:17,310,426...17,313,093
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
treatment |
ISO IEP |
|
RGD |
PMID:29401608 PMID:30192013 PMID:25592162 PMID:29902864 |
RGD:14700887, RGD:14700906, RGD:14700894, RGD:14700893 |
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
|
RGD |
PMID:30502657 |
RGD:38599215 |
NCBI chr14:91,176,931...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
|
IDA |
|
RGD |
PMID:21059295 |
RGD:10395351 |
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Fas |
Fas cell surface death receptor |
|
ISO |
protein:increased expression:lymphocyte: |
RGD |
PMID:26429926 |
RGD:14700711 |
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
|
ISO |
|
RGD |
PMID:15932176 PMID:26937962 |
RGD:14700973, RGD:11060494 |
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
|
ISO |
|
RGD |
PMID:15932176 PMID:26937962 |
RGD:14700973, RGD:11060494 |
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Hfe |
homeostatic iron regulator |
|
IEP |
mRNA:increased expression:liver, Kupffer cell (rat) |
RGD |
PMID:18599584 |
RGD:8694397 |
NCBI chr17:41,413,451...41,421,502
Ensembl chr17:41,413,451...41,421,502
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
|
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:17085342 |
RGD:9068897 |
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Igf2 |
insulin-like growth factor 2 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:18505416 |
RGD:5510002 |
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
G |
Il1b |
interleukin 1 beta |
|
IEP |
protein:increased expression:serum (rat) |
RGD |
PMID:23009062 |
RGD:7204488 |
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
|
ISO |
mRNA:decreased expression:liver (human) |
RGD |
PMID:22459801 |
RGD:6892954 |
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Lpl |
lipoprotein lipase |
treatment |
IEP |
|
RGD |
PMID:28442378 |
RGD:13794376 |
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Mif |
macrophage migration inhibitory factor |
|
IEP |
protein:increased expression:liver |
RGD |
PMID:11798463 |
RGD:1642007 |
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
|
|
G |
Mir122 |
microRNA 122 |
|
ISO |
miRNA:decreased expression:hepatocyte |
RGD |
PMID:28987423 |
RGD:14401600 |
NCBI chr18:58,758,703...58,758,787
|
|
G |
Mir155 |
microRNA 155 |
|
ISO |
|
RGD |
PMID:28492308 |
RGD:25314298 |
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
|
|
G |
Mir223 |
microRNA 223 |
severity |
ISO |
|
RGD |
PMID:27679493 |
RGD:21408575 |
NCBI chr X:61,141,887...61,141,996
Ensembl chr X:61,141,887...61,141,996
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
IEP |
protein:increased expression:liver |
RGD |
PMID:17374579 |
RGD:1642042 |
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
disease_progression severity |
ISO |
mRNA:increased expression:liver |
RGD |
PMID:26576483 PMID:26576483 |
RGD:14695016, RGD:14695016 |
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Nedd8 |
NEDD8 ubiquitin like modifier |
|
ISO |
|
RGD |
PMID:12533840 |
RGD:1549458 |
NCBI chr15:29,153,556...29,165,575
Ensembl chr15:29,153,556...29,166,160
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
treatment severity |
ISO |
DNA:SNP:promoter:rs35652124(human) |
RGD |
PMID:31906014 PMID:31340446 |
RGD:21201307, RGD:21201311 |
NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Otc |
ornithine transcarbamylase |
|
IEP |
protein:increased expression:serum (rat) |
RGD |
PMID:19101528 |
RGD:4144059 |
NCBI chr X:12,453,834...12,529,954
Ensembl chr X:12,453,834...12,566,918
|
|
G |
Plaur |
plasminogen activator, urokinase receptor |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:22098627 |
RGD:6484116 |
NCBI chr 1:80,053,441...80,068,384
Ensembl chr 1:80,050,324...80,068,595
|
|
G |
Pnpla3 |
patatin-like phospholipase domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19946271 |
|
NCBI chr 7:115,293,538...115,314,077
Ensembl chr 7:115,293,538...115,314,077
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
severity |
ISO |
DNA:knockout::increased severity in knockouts (mouse) |
RGD |
PMID:15382117 |
RGD:5683636 |
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27765815 |
|
NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968
|
|
G |
Psmd14 |
proteasome 26S subunit, non-ATPase 14 |
|
IEP |
protein:decreased expression:liver, cytosolic proteasome complex (rat) |
RGD |
PMID:19609968 |
RGD:9480236 |
NCBI chr 3:46,254,338...46,347,076
Ensembl chr 3:46,254,330...46,347,076
|
|
G |
Rbp4 |
retinol binding protein 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762690 |
|
NCBI chr 1:235,893,917...235,901,315
Ensembl chr 1:235,893,917...235,901,399
|
|
G |
Slc39a13 |
solute carrier family 39 member 13 |
|
IEP |
protein:increased expression:liver, endoplasmic reticulum (rat) |
RGD |
PMID:25767260 |
RGD:11553884 |
NCBI chr 3:77,039,411...77,047,536
Ensembl chr 3:77,037,565...77,049,226
|
|
G |
Sod1 |
superoxide dismutase 1 |
treatment |
ISO |
human gene in a rat model |
RGD |
PMID:11266387 |
RGD:9587792 |
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
treatment |
ISO |
|
RGD |
PMID:32236798 |
RGD:27095880 |
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18703563 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Tbxas1 |
thromboxane A synthase 1 |
|
IEP |
mRNA,protein:increased expression:liver, Kupffer cell: |
RGD |
PMID:9262373 |
RGD:11059607 |
NCBI chr 4:67,664,963...67,837,096
Ensembl chr 4:67,665,007...67,837,096
|
|
G |
Tert |
telomerase reverse transcriptase |
|
ISO |
mRNA,protein,activity:increased expression, increased activity:kupffer cell: |
RGD |
PMID:26725521 |
RGD:11574970 |
NCBI chr 1:29,637,213...29,659,509
Ensembl chr 1:29,637,506...29,659,561
|
|
G |
Tlr3 |
toll-like receptor 3 |
treatment |
ISO |
|
RGD |
PMID:23023014 PMID:30870678 |
RGD:21079426, RGD:21079436 |
NCBI chr16:46,821,980...46,837,900
Ensembl chr16:46,822,039...46,836,545
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
IMP IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:9397994 PMID:7556590 PMID:15670576 |
RGD:14398736, RGD:14995472, RGD:14995456 |
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Uchl5 |
ubiquitin C-terminal hydrolase L5 |
|
IEP |
protein:decreased expression:liver, cytosolic proteasome complex |
RGD |
PMID:19609968 |
RGD:9480236 |
NCBI chr13:55,520,722...55,556,503
Ensembl chr13:55,520,729...55,556,502
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:24959006 |
RGD:15014784 |
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Igf1 |
insulin-like growth factor 1 |
|
IEP |
|
RGD |
PMID:23016131 |
RGD:10402569 |
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
|
IEP |
|
RGD |
PMID:23016131 |
RGD:10402569 |
NCBI chr 1:121,549,839...121,838,545
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Igf2 |
insulin-like growth factor 2 |
|
IEP |
|
RGD |
PMID:23016131 |
RGD:10402569 |
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
|
G |
Cftr |
CF transmembrane conductance regulator |
|
ISO |
DNA:missense mutations: :p.L1156F, Q1352H (human) |
RGD |
PMID:26089335 |
RGD:11566036 |
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
|
|
G |
Pthlh |
parathyroid hormone-like hormone |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22280800 |
|
NCBI chr 4:180,188,792...180,199,847
Ensembl chr 4:180,188,792...180,199,847
|
|
G |
Ugt1a7c |
UDP glucuronosyltransferase 1 family, polypeptide A7C |
|
ISO |
DNA:polymorphisms: :p.N129K, p.R131K, p.W208R (human) |
RGD |
PMID:12806614 |
RGD:2317503 |
NCBI chr 9:88,739,577...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
|
G |
Ache |
acetylcholinesterase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16470869 |
|
NCBI chr12:19,407,359...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr10:38,439,914...38,501,182
Ensembl chr10:38,440,080...38,498,757
|
|
G |
Adora2a |
adenosine A2a receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20799992 |
|
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
|
|
G |
Ak5 |
adenylate kinase 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 2:241,397,297...241,581,483
Ensembl chr 2:241,397,297...241,581,458
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15982448 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Aoah |
acyloxyacyl hydrolase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr17:43,808,110...44,049,458
Ensembl chr17:43,809,638...44,049,148
|
|
G |
Arrb2 |
arrestin, beta 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17233643 |
|
NCBI chr10:55,146,887...55,154,854
Ensembl chr10:55,146,818...55,154,850
|
|
G |
Astn2 |
astrotactin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 5:78,758,142...79,744,021
Ensembl chr 5:78,758,142...79,748,273
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20736000 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Cchcr1 |
coiled-coil alpha-helical rod protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr20:3,205,675...3,218,437
Ensembl chr20:3,205,676...3,218,308
|
|
G |
Cd55 |
CD55 molecule (Cromer blood group) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr13:41,857,242...41,885,966
Ensembl chr13:41,857,395...41,885,831
|
|
G |
Cdh13 |
cadherin 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr19:46,349,562...47,387,462
Ensembl chr19:46,349,430...47,387,459
|
|
G |
Cfh |
complement factor H |
|
ISO IEP |
protein:increased expression:serum: protein:increased expression:serum, hippocampus: |
RGD |
PMID:22871478 PMID:22871478 |
RGD:7364944, RGD:7364944 |
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
|
|
G |
Col28a1 |
collagen type XXVIII alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 4:36,069,980...36,223,128
Ensembl chr 4:36,069,970...36,223,220
|
|
G |
Comt |
catechol-O-methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15274053 |
|
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Csmd1 |
CUB and Sushi multiple domains 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr16:72,218,189...73,818,380
Ensembl chr16:72,218,503...73,817,614
|
|
G |
Cubn |
cubilin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr17:76,385,046...76,593,133
Ensembl chr17:76,385,060...76,593,231
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18280655 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Dcstamp |
dendrocyte expressed seven transmembrane protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 7:70,807,455...70,822,067
Ensembl chr 7:70,807,581...70,822,078
|
|
G |
Drd1 |
dopamine receptor D1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18363855 PMID:19444617 |
|
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
|
|
G |
Drd2 |
dopamine receptor D2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18363855 PMID:18555060 PMID:19940168 |
|
NCBI chr 8:49,708,903...49,772,888
Ensembl chr 8:49,708,927...49,772,875
|
|
G |
Drd3 |
dopamine receptor D3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19940168 |
|
NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596
|
|
G |
Drd4 |
dopamine receptor D4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15274053 |
|
NCBI chr 1:196,396,366...196,400,824
Ensembl chr 1:196,396,366...196,399,553
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19598248 |
|
NCBI chr13:92,714,315...92,744,124
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Fhit |
fragile histidine triad diadenosine triphosphatase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340
|
|
G |
Fkbp15 |
FKBP prolyl isomerase family member 15 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 5:75,750,786...75,815,038
Ensembl chr 5:75,750,787...75,814,990
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19689456 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Gabrg2 |
gamma-aminobutyric acid type A receptor subunit gamma 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15772696 |
|
NCBI chr10:26,376,805...26,463,680
Ensembl chr10:26,374,694...26,464,346
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17356005 |
|
NCBI chr 2:56,893,992...56,919,935
Ensembl chr 2:56,895,010...56,917,209
|
|
G |
Grm2 |
glutamate metabotropic receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20211215 |
|
NCBI chr 8:107,280,099...107,293,159
Ensembl chr 8:107,280,099...107,293,146
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19254865 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15729709 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18186040 PMID:19254865 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Hdac8 |
histone deacetylase 8 |
|
IEP |
mRNA:decreased expression:striatum (rat) |
RGD |
PMID:25452209 |
RGD:9681719 |
NCBI chr X:67,385,288...67,593,014
Ensembl chr X:67,385,289...67,592,923
|
|
G |
Hs3st4 |
heparan sulfate-glucosamine 3-sulfotransferase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 1:178,539,078...178,944,851
Ensembl chr 1:178,539,093...178,944,107
|
|
G |
Htr1b |
5-hydroxytryptamine receptor 1B |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:10780831 |
|
NCBI chr 8:82,513,572...82,534,892
Ensembl chr 8:82,517,360...82,534,549
|
|
G |
Htr3a |
5-hydroxytryptamine receptor 3A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19689456 |
|
NCBI chr 8:49,242,018...49,254,475
Ensembl chr 8:49,242,020...49,254,389
|
|
G |
Htr6 |
5-hydroxytryptamine receptor 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20705401 |
|
NCBI chr 5:151,295,269...151,312,853
Ensembl chr 5:151,296,662...151,311,912
|
|
G |
Large1 |
LARGE xylosyl- and glucuronyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr19:11,603,129...12,048,930
Ensembl chr19:11,603,129...12,048,930
|
|
G |
Lingo2 |
leucine rich repeat and Ig domain containing 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 5:50,370,744...51,687,252
Ensembl chr 5:50,367,101...50,516,956
|
|
G |
Map2k5 |
mitogen activated protein kinase kinase 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 8:63,625,220...63,852,090
Ensembl chr 8:63,625,221...63,851,983
|
|
G |
Mtarc1 |
mitochondrial amidoxime reducing component 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr13:96,324,377...96,362,677
Ensembl chr13:96,339,757...96,397,796
|
|
G |
Mtarc2 |
mitochondrial amidoxime reducing component 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr13:96,362,810...96,397,284
|
|
G |
Myo5b |
myosin Vb |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr18:68,038,759...68,341,568
Ensembl chr18:68,038,759...68,338,745
|
|
G |
Nos1 |
nitric oxide synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15542708 |
|
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
|
|
G |
Npy1r |
neuropeptide Y receptor Y1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19566775 |
|
NCBI chr16:23,037,788...23,047,330
Ensembl chr16:23,037,789...23,046,759
|
|
G |
Nrg1 |
neuregulin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr16:59,250,658...60,303,024
Ensembl chr16:59,250,854...60,296,884
|
|
G |
Oprm1 |
opioid receptor, mu 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16402083 |
|
NCBI chr 1:43,160,057...43,413,409
Ensembl chr 1:43,160,057...43,413,409
|
|
G |
PCOLCE2 |
procollagen C-endopeptidase enhancer 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 8:96,193,461...96,251,116
Ensembl chr 8:96,193,461...96,251,114
|
|
G |
Pde4b |
phosphodiesterase 4B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 5:116,799,827...117,367,707
Ensembl chr 5:116,799,971...117,367,696
|
|
G |
Pde4d |
phosphodiesterase 4D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 2:40,014,933...41,529,190
Ensembl chr 2:40,019,933...41,525,884
|
|
G |
Pde6c |
phosphodiesterase 6C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 1:235,909,473...235,965,460
Ensembl chr 1:235,909,775...235,965,315
|
|
G |
Pdyn |
prodynorphin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16529859 |
|
NCBI chr 3:116,900,990...116,913,334
Ensembl chr 3:116,900,992...116,913,334
|
|
G |
Pick1 |
protein interacting with PRKCA 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17606663 |
|
NCBI chr 7:110,796,623...110,816,850
Ensembl chr 7:110,797,117...110,816,848
|
|
G |
Plat |
plasminogen activator, tissue type |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15659235 |
|
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
|
|
G |
Pou5f1 |
POU class 5 homeobox 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
|
|
G |
Prdm2 |
PR/SET domain 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 5:155,421,066...155,531,884
Ensembl chr 5:155,422,134...155,531,825
|
|
G |
Prkg1 |
protein kinase cGMP-dependent 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 1:228,409,883...229,638,794
Ensembl chr 1:228,408,947...229,639,080
|
|
G |
Prokr2 |
prokineticin receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20576534 |
|
NCBI chr 3:119,624,738...119,639,442
Ensembl chr 3:119,627,601...119,635,718
|
|
G |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr16:21,465,643...22,035,846
Ensembl chr16:21,465,639...22,034,547
|
|
G |
Raly |
RALY heterogeneous nuclear ribonucleoprotein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 3:143,306,039...143,370,542
Ensembl chr 3:143,306,300...143,370,539
|
|
G |
Rapgef5 |
Rap guanine nucleotide exchange factor 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 6:138,445,127...138,679,943
Ensembl chr 6:138,437,991...138,679,936
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19689456 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rgs17 |
regulator of G-protein signaling 17 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 1:42,222,248...42,324,625
Ensembl chr 1:42,227,070...42,324,609
|
|
G |
Serpina5 |
serpin family A member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 6:123,009,224...123,028,412
Ensembl chr 6:123,023,306...123,028,407
|
|
G |
Sgcz |
sarcoglycan zeta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr16:53,660,283...54,740,811
Ensembl chr16:53,660,502...54,735,193
|
|
G |
Sh3rf3 |
SH3 domain containing ring finger 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr20:26,765,278...27,099,261
Ensembl chr20:26,765,015...27,099,257
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12931138 |
|
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19689456 |
|
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
|
|
G |
Slc6a9 |
solute carrier family 6 member 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17582620 |
|
NCBI chr 5:131,374,562...131,408,733
Ensembl chr 5:131,374,542...131,408,728
|
|
G |
Smyd3 |
SET and MYND domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr13:90,709,263...91,266,209
Ensembl chr13:90,709,270...91,266,253
|
|
G |
Snca |
synuclein alpha |
treatment |
IMP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:15542733 PMID:32278788 PMID:20551914 |
RGD:13506280 |
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
|
|
G |
Trpm3 |
transient receptor potential cation channel, subfamily M, member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 1:219,673,200...220,557,610
Ensembl chr 1:219,672,892...220,560,717
|
|
G |
Usp48 |
ubiquitin specific peptidase 48 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 5:149,800,189...149,867,838
Ensembl chr 5:149,800,179...149,867,719
|
|
G |
Zfp385d |
zinc finger protein 385D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr15:5,040,182...5,849,975
Ensembl chr15:5,042,572...5,423,367
|
|
G |
Zfp423 |
zinc finger protein 423 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr19:19,111,538...19,407,371
Ensembl chr19:19,110,238...19,407,373
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
susceptibility |
ISO |
DNA:missense mutation:cds:p.G671V (human) |
RGD |
PMID:16330681 |
RGD:11041175 |
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Capn2 |
calpain 2 |
treatment |
IEP |
|
RGD |
PMID:25634181 |
RGD:13792617 |
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
|
ISO |
associated with Leukemia, Myeloid, Acute;DNA:SNP:exon:p.K751Q (rs13181) (human) |
RGD |
PMID:24284041 |
RGD:11252190 |
NCBI chr 1:79,033,342...79,047,102
Ensembl chr 1:79,033,326...79,047,102
|
|
|
G |
Akap9 |
A-kinase anchoring protein 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 4:30,056,738...30,192,716
Ensembl chr 4:30,056,738...30,192,606
|
|
G |
Alad |
aminolevulinate dehydratase |
|
IEP |
protein:decreased activity:blood (rat) |
RGD |
PMID:19022878 |
RGD:4144202 |
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
|
|
G |
Aqp9 |
aquaporin 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19805235 |
|
NCBI chr 8:71,797,231...71,837,485
Ensembl chr 8:71,797,234...71,837,395
|
|
G |
As3mt |
arsenite methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:21447609 PMID:26366667 PMID:35226250 |
|
NCBI chr 1:245,595,939...245,628,921
Ensembl chr 1:245,596,108...245,627,872
|
|
G |
Atxn7 |
ataxin 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr15:11,117,360...11,262,818
Ensembl chr15:11,118,886...11,263,106
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr10:68,466,469...68,467,941
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccrl2 |
C-C motif chemokine receptor like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 8:111,034,279...111,036,914
Ensembl chr 8:111,034,279...111,036,664
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cd83 |
CD83 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr17:20,887,309...20,907,009
Ensembl chr17:20,887,309...20,907,083
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
ISO |
protein:increased expression:skin: |
RGD |
PMID:11860939 |
RGD:8662429 |
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Crp |
C-reactive protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22521605 |
|
NCBI chr13:85,131,635...85,175,179
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12569548 |
|
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
|
|
G |
Ercc3 |
ERCC excision repair 3, TFIIH core complex helicase subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12569548 |
|
NCBI chr18:23,883,613...23,914,326
Ensembl chr18:23,883,580...23,914,329
|
|
G |
Ercc4 |
ERCC excision repair 4, endonuclease catalytic subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12569548 |
|
NCBI chr10:2,416,259...2,448,364
Ensembl chr10:2,419,038...2,448,369
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
|
|
G |
Golga4 |
golgin A4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 8:118,208,200...118,285,003
|
|
G |
Gsr |
glutathione-disulfide reductase |
|
IEP |
|
RGD |
PMID:25209654 |
RGD:10401880 |
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
|
|
G |
Ier3 |
immediate early response 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Igf2bp2 |
insulin-like growth factor 2 mRNA binding protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35226250 |
|
NCBI chr11:78,874,402...78,974,392
Ensembl chr11:78,874,414...78,974,377
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Inpp5a |
inositol polyphosphate-5-phosphatase A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25759212 |
|
NCBI chr 1:194,190,086...194,380,429
Ensembl chr 1:194,190,393...194,380,428
|
|
G |
Kcnj2 |
potassium inwardly-rectifying channel, subfamily J, member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr10:96,060,849...96,071,401
Ensembl chr10:96,060,821...96,071,445
|
|
G |
Krt10 |
keratin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19953893 |
|
NCBI chr10:84,338,695...84,343,279
Ensembl chr10:84,338,706...84,343,701
|
|
G |
Mettl14 |
methyltransferase 14, N6-adenosine-methyltransferase subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35226250 |
|
NCBI chr 2:211,530,598...211,546,858
Ensembl chr 2:211,530,602...211,546,821
|
|
G |
Minpp1 |
multiple inositol-polyphosphate phosphatase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 1:230,354,483...230,379,730
Ensembl chr 1:230,354,438...230,379,730
|
|
G |
Mir145 |
microRNA 145 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29705342 |
|
NCBI chr18:55,099,640...55,099,727
Ensembl chr18:55,099,640...55,099,727
|
|
G |
Mir155 |
microRNA 155 |
|
ISO |
miRNA:increased expression:serum |
RGD |
PMID:27913196 |
RGD:25314296 |
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
|
|
G |
Mt1 |
metallothionein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19953893 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24384392 |
|
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
|
|
G |
N4bp2l2 |
NEDD4 binding protein 2-like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr12:137,342...200,294
Ensembl chr12:103,590...197,784
|
|
G |
Ndufb8 |
NADH:ubiquinone oxidoreductase subunit B8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 1:243,408,659...243,413,701
Ensembl chr 1:243,408,619...243,413,817
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35226250 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877
|
|
G |
Pde4b |
phosphodiesterase 4B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 5:116,799,827...117,367,707
Ensembl chr 5:116,799,971...117,367,696
|
|
G |
Peli1 |
pellino E3 ubiquitin protein ligase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr14:95,254,274...95,309,168
Ensembl chr14:95,254,589...95,308,285
|
|
G |
Pfkfb3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr17:66,983,629...67,064,702
Ensembl chr17:66,983,686...67,063,125
|
|
G |
Pias1 |
protein inhibitor of activated STAT, 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 8:63,338,150...63,451,670
Ensembl chr 8:63,338,150...63,438,905
|
|
G |
Pnp |
purine nucleoside phosphorylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18414634 |
|
NCBI chr15:24,170,456...24,178,274
Ensembl chr15:24,170,602...24,203,986
|
|
G |
Ptx3 |
pentraxin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 2:150,487,513...150,493,323
Ensembl chr 2:150,487,513...150,493,323
|
|
G |
Rfx3 |
regulatory factor X3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 1:225,449,872...225,709,622
Ensembl chr 1:225,456,187...225,709,402
|
|
G |
Rgs1 |
regulator of G-protein signaling 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr13:56,018,529...56,022,939
Ensembl chr13:56,018,554...56,022,984
|
|
G |
Rnf20 |
ring finger protein 20 |
|
ISO |
protein:increased expression:urine (human) |
RGD |
PMID:21136906 |
RGD:9831407 |
NCBI chr 5:63,976,063...64,001,754
Ensembl chr 5:63,976,045...64,001,754
|
|
G |
Rufy3 |
RUN and FYVE domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr14:19,431,530...19,506,531
Ensembl chr14:19,432,524...19,507,004
|
|
G |
Sfpq |
splicing factor proline and glutamine rich |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 5:139,338,034...139,353,476
Ensembl chr 5:139,338,075...139,353,472
|
|
G |
Skil |
SKI-like proto-oncogene |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 2:112,247,047...112,275,176
Ensembl chr 2:112,247,051...112,275,080
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sox18 |
SRY-box transcription factor 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 3:168,785,488...168,787,290
Ensembl chr 3:168,785,490...168,787,290
|
|
G |
Srp68 |
signal recognition particle 68 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr10:101,481,213...101,508,035
Ensembl chr10:101,481,212...101,508,035
|
|
G |
Ssbp1 |
single stranded DNA binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 4:69,266,024...69,276,135
Ensembl chr 4:69,266,102...69,276,135
|
|
G |
Taf1d |
TATA-box binding protein associated factor, RNA polymerase I subunit D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 8:12,146,511...12,156,647
Ensembl chr 8:12,146,605...12,156,618
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfaip6 |
TNF alpha induced protein 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
|
|
G |
Tnik |
TRAF2 and NCK interacting kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 2:111,184,352...111,587,993
Ensembl chr 2:111,184,387...111,580,750
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18621066 PMID:19203779 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tra2a |
transformer 2 alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 4:78,220,838...78,239,737
Ensembl chr 4:78,220,883...78,239,712
|
|
G |
Trappc10 |
trafficking protein particle complex subunit 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr20:10,438,737...10,499,074
Ensembl chr20:10,438,737...10,499,074
|
|
G |
Ube2e1 |
ubiquitin-conjugating enzyme E2E 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr15:7,439,502...7,493,410
Ensembl chr15:7,439,759...7,493,400
|
|
G |
Uso1 |
USO1 vesicle transport factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr14:15,866,638...15,932,185
Ensembl chr14:15,866,638...15,932,171
|
|
G |
Usp13 |
ubiquitin specific peptidase 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 2:115,576,912...115,689,153
Ensembl chr 2:115,577,091...115,686,222
|
|
G |
Zfand6 |
zinc finger AN1-type containing 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 1:138,581,002...138,652,052
Ensembl chr 1:138,581,002...138,651,939
|
|
G |
Zfp267 |
zinc finger protein 267 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 2:119,017,244...119,035,885
Ensembl chr 2:119,017,285...119,031,900
|
|
|
G |
Cacng6 |
calcium voltage-gated channel auxiliary subunit gamma 6 |
susceptibility |
ISO |
DNA:SNP,haplotype:rs192808(human) |
RGD |
PMID:20860846 |
RGD:13524562 |
NCBI chr 1:65,732,910...65,747,377
Ensembl chr 1:65,732,632...65,747,341
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20485159 PMID:20022477 |
RGD:4145619 |
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 PMID:17641958 PMID:20485159 |
|
NCBI chr X:71,661,415...71,690,158
Ensembl chr X:71,663,821...71,690,121
|
|
G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
|
ISO |
DNA:SNPs: :-819T>G, 2078C>T, 2534A>G (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16502481 PMID:20485159 PMID:15970796 |
RGD:5144000 |
NCBI chr15:48,190,251...48,229,906
Ensembl chr15:48,189,073...48,304,136
|
|
G |
Fancc |
FA complementation group C |
|
ISO |
DNA:haplotype::rs4647416(human) |
RGD |
PMID:21670957 |
RGD:11045795 |
NCBI chr17:1,680,660...1,822,610
Ensembl chr17:1,681,324...1,829,376
|
|
G |
Il4 |
interleukin 4 |
susceptibility |
ISO |
DNA:SNPs:promoter,5'UTR,intron:multiple |
RGD |
PMID:20921925 |
RGD:11528633 |
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Ltc4s |
leukotriene C4 synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9393345 PMID:9466979 PMID:10970818 PMID:20485159 |
|
NCBI chr10:34,560,476...34,562,790
Ensembl chr10:34,560,360...34,562,651
|
|
G |
Ms4a2 |
membrane spanning 4-domains A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 |
|
NCBI chr 1:208,440,179...208,448,716
Ensembl chr 1:208,440,361...208,448,310
|
|
G |
Postn |
periostin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18391768 |
|
NCBI chr 2:138,527,714...138,559,098
Ensembl chr 2:138,527,696...138,559,099
|
|
G |
Ptgdr2 |
prostaglandin D2 receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20485159 |
|
NCBI chr 1:207,585,088...207,590,275
Ensembl chr 1:207,587,917...207,589,213
|
|
G |
Ptger2 |
prostaglandin E receptor 2 |
|
ISO |
ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to CTD Direct Evidence: marker/mechanism |
ClinVar CTD |
PMID:15496426 PMID:16502481 |
|
NCBI chr15:18,215,013...18,228,714
Ensembl chr15:18,217,285...18,228,714
|
|
G |
Ptgir |
prostaglandin I2 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20485159 |
|
NCBI chr 1:77,579,596...77,581,979
Ensembl chr 1:77,579,596...77,581,979
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
protein:increased expression:mast cell CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16502481 PMID:20485159 PMID:9487340 |
RGD:5143936 |
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
|
|
G |
RT1-Ba |
RT1 class II, locus Ba |
susceptibility |
ISO |
|
RGD |
PMID:25975240 |
RGD:11074090 |
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
|
|
G |
RT1-Bb |
RT1 class II, locus Bb |
susceptibility |
ISO |
|
RGD |
PMID:25975240 |
RGD:11074090 |
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
susceptibility |
ISO |
|
RGD |
PMID:25975240 |
RGD:11074090 |
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
|
|
G |
Tap2 |
transporter 2, ATP binding cassette subfamily B member |
|
ISO |
|
RGD |
PMID:21796142 |
RGD:5147839 |
NCBI chr20:4,636,347...4,650,387
Ensembl chr20:4,636,357...4,650,407
|
|
G |
Tbx21 |
T-box transcription factor 21 |
|
ISO |
ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to CTD Direct Evidence: marker/mechanism |
ClinVar CTD |
PMID:15806396 PMID:16502481 |
|
NCBI chr10:82,082,322...82,098,831
Ensembl chr10:82,082,322...82,098,831
|
|
G |
Tbxa2r |
thromboxane A2 receptor |
susceptibility |
ISO |
DNA:polymorphism: :795T>C (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16502481 PMID:20485159 PMID:15898979 |
RGD:11059537 |
NCBI chr 7:8,383,347...8,390,753
Ensembl chr 7:8,383,378...8,388,176
|
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
|
ISO |
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance |
ClinVar |
PMID:17959182 PMID:21558275 PMID:30643255 |
|
NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874
|
|
G |
Ptger2 |
prostaglandin E receptor 2 |
|
ISO |
|
OMIM |
|
|
NCBI chr15:18,215,013...18,228,714
Ensembl chr15:18,217,285...18,228,714
|
|
G |
Tbx21 |
T-box transcription factor 21 |
|
ISO |
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance |
OMIM ClinVar |
PMID:25741868 |
|
NCBI chr10:82,082,322...82,098,831
Ensembl chr10:82,082,322...82,098,831
|
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
ISO IEP |
protein:increased expression, increased nitration |
RGD |
PMID:25236742 PMID:29404485 PMID:25236742 |
RGD:14700891, RGD:14700911, RGD:14700891 |
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
|
ISO |
protein:increased expression:nucleus accumbens: |
RGD |
PMID:23423140 |
RGD:9588287 |
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Efhd2 |
EF-hand domain family, member D2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28397836 |
|
NCBI chr 5:154,160,945...154,176,980
Ensembl chr 5:154,160,946...154,176,980
|
|
G |
Mir125a |
microRNA 125a |
|
IEP |
RNA:decreased expression:neuron |
RGD |
PMID:27085842 |
RGD:26884454 |
NCBI chr 1:58,677,626...58,677,710
Ensembl chr 1:58,677,626...58,677,710
|
|
G |
Mir223 |
microRNA 223 |
|
ISO |
RNA:increased expression:serum RNA:increased expression:serum, neutrophil,liver |
RGD |
PMID:27679493 PMID:27679493 |
RGD:21408575, RGD:21408575 |
NCBI chr X:61,141,887...61,141,996
Ensembl chr X:61,141,887...61,141,996
|
|
G |
Oprl1 |
opioid related nociceptin receptor 1 |
|
ISO |
|
RGD |
PMID:29197086 |
RGD:14348965 |
NCBI chr 3:168,831,934...168,839,920
Ensembl chr 3:168,834,003...168,839,920
|
|
G |
Sirt1 |
sirtuin 1 |
|
IEP |
|
RGD |
PMID:24416161 |
RGD:9495933 |
NCBI chr20:25,307,143...25,329,260
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Slc23a2 |
solute carrier family 23 member 2 |
|
IEP |
|
RGD |
PMID:27085842 |
RGD:26884454 |
NCBI chr 3:119,302,651...119,395,289
Ensembl chr 3:119,302,666...119,460,343
|
|
|
G |
Ache |
acetylcholinesterase |
treatment |
IEP |
|
RGD |
PMID:27491636 |
RGD:152995409 |
NCBI chr12:19,407,359...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Ada |
adenosine deaminase |
treatment |
IEP |
|
RGD |
PMID:27491636 |
RGD:152995409 |
NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088
|
|
G |
Cpa1 |
carboxypeptidase A1 |
|
IEP |
protein:increased activity:small intestine (rat) |
RGD |
PMID:15865404 |
RGD:1578424 |
NCBI chr 4:59,257,417...59,263,544
Ensembl chr 4:59,257,417...59,263,544
|
|
G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
IEP |
protein:increased activity:plasma: |
RGD |
PMID:24361405 |
RGD:9685430 |
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
treatment |
IEP |
|
RGD |
PMID:24954678 |
RGD:11352769 |
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20643113 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Gsr |
glutathione-disulfide reductase |
treatment |
IEP |
|
RGD |
PMID:24200859 |
RGD:10401881 |
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Htt |
huntingtin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19845833 |
|
NCBI chr14:75,845,836...75,996,094
Ensembl chr14:75,845,836...75,995,070
|
|
G |
Il6 |
interleukin 6 |
|
IEP |
in males;protein:increased expression, increased activity:plasma (rat) |
RGD |
PMID:19462680 |
RGD:11060270 |
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Mt3 |
metallothionein 3 |
|
ISO |
|
RGD |
PMID:20371971 |
RGD:6480494 |
NCBI chr19:10,848,754...10,850,158
Ensembl chr19:10,848,755...10,850,158
|
|
G |
Nudt1 |
nudix hydrolase 1 |
|
IEP |
|
RGD |
PMID:11817101 |
RGD:633232 |
NCBI chr12:14,302,514...14,309,559
Ensembl chr12:14,302,694...14,305,826
|
|
G |
Selenop |
selenoprotein P |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20643113 |
|
NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:52,498,339...52,508,852
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19625010 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21041608 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Apol2 |
apolipoprotein L, 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17205118 |
|
NCBI chr 7:109,331,367...109,338,632
Ensembl chr 7:109,331,392...109,338,558
|
|
G |
Calm1 |
calmodulin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17205118 |
|
NCBI chr 6:119,487,691...119,495,759
Ensembl chr 6:119,487,621...119,498,227
|
|
G |
Calm2 |
calmodulin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17205118 |
|
NCBI chr 6:7,091,624...7,104,284
Ensembl chr 6:7,091,567...7,104,287
|
|
G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17205118 |
|
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19016476 |
|
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
|
|
G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17205118 |
|
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
|
|
G |
Gcc1 |
GRIP and coiled-coil domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17205118 |
|
NCBI chr 4:57,030,817...57,042,682
Ensembl chr 4:57,032,314...57,042,663
|
|
G |
Scarb1 |
scavenger receptor class B, member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17205118 |
|
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
|
|
|
G |
Chrna3 |
cholinergic receptor nicotinic alpha 3 subunit |
|
IEP |
|
RGD |
PMID:24704181 |
RGD:151347543 |
NCBI chr 8:55,401,981...55,415,012
Ensembl chr 8:55,401,702...55,415,165
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
IEP IDA |
|
RGD |
PMID:20422170 PMID:19520142 |
RGD:4145288, RGD:4145306 |
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Mbp |
myelin basic protein |
|
IEP |
protein:decreased expression:brain: |
RGD |
PMID:23146304 |
RGD:7327205 |
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
|
|
G |
Nos1 |
nitric oxide synthase 1 |
|
IMP |
|
RGD |
PMID:14761684 |
RGD:13825130 |
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
|
|
G |
Xdh |
xanthine dehydrogenase |
|
IMP IEP |
|
RGD |
PMID:17433579 PMID:8248931 |
RGD:13209022, RGD:13210748 |
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|
|
G |
Fadd |
Fas associated via death domain |
treatment |
IEP |
|
RGD |
PMID:25687490 |
RGD:11341810 |
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Gfer |
growth factor, augmenter of liver regeneration |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15968720 |
|
NCBI chr10:13,718,489...13,721,782
Ensembl chr10:13,718,489...13,720,869
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
IEP |
|
RGD |
PMID:24748974 |
RGD:10755718 |
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Ltf |
lactotransferrin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16141546 |
|
NCBI chr 8:110,999,948...111,022,795
Ensembl chr 8:110,999,948...111,022,795
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
IEP |
|
RGD |
PMID:23684718 |
RGD:11035220 |
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Ucp2 |
uncoupling protein 2 |
|
IEP |
protein:increased expression:liver |
RGD |
PMID:19104935 |
RGD:7204431 |
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
|
|
|
G |
Agt |
angiotensinogen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33676887 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Bche |
butyrylcholinesterase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:26145887 |
|
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Bmp2 |
bone morphogenetic protein 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29800642 |
|
NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:35792220 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29959987 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Csf1 |
colony stimulating factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32068018 |
|
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
|
|
G |
Fas |
Fas cell surface death receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34713381 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34713381 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29305325 |
|
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32068018 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Mettl14 |
methyltransferase 14, N6-adenosine-methyltransferase subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34648132 |
|
NCBI chr 2:211,530,598...211,546,858
Ensembl chr 2:211,530,602...211,546,821
|
|
G |
Mir143 |
microRNA 143 |
ameliorates |
ISO |
|
RGD |
PMID:32170053 |
RGD:155883163 |
NCBI chr18:55,101,006...55,101,110
Ensembl chr18:55,101,006...55,101,110
|
|
G |
Mir208a |
microRNA 208a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26454886 |
|
NCBI chr15:28,425,570...28,425,652
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
ISO |
associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:polymorphism: :894G>T(human) |
RGD |
PMID:26345518 |
RGD:11533645 |
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Nppb |
natriuretic peptide B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29959987 |
|
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Nrg1 |
neuregulin 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29305325 |
|
NCBI chr16:59,250,658...60,303,024
Ensembl chr16:59,250,854...60,296,884
|
|
G |
Rac1 |
Rac family small GTPase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28710503 |
|
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
|
|
G |
Rarg |
retinoic acid receptor, gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26237429 |
|
NCBI chr 7:133,367,833...133,390,301
Ensembl chr 7:133,367,833...133,390,177
|
|
G |
Sirt6 |
sirtuin 6 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:34713381 |
|
NCBI chr 7:8,082,312...8,087,776
Ensembl chr 7:8,082,364...8,098,914
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29959987 |
|
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29959987 PMID:32068018 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30009776 PMID:34713381 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
|
G |
Aass |
aminoadipate-semialdehyde synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 4:51,606,461...51,663,136
Ensembl chr 4:51,606,462...51,663,136
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
severity |
ISO |
DNA:SNP: :rs2287616(human) |
RGD |
PMID:27293027 |
RGD:14402413 |
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
severity susceptibility |
ISO |
DNA:SNP::2677G>T/A(rs2032582)(human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20623750 PMID:26134275 PMID:26134275 PMID:27296832 |
RGD:11041130, RGD:14700895 |
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27193730 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18466103 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter:-24C>T(human) |
CTD RGD |
PMID:18381794 PMID:18466103 PMID:17241877 PMID:25196354 |
RGD:14700814, RGD:14700812 |
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abi1 |
abl-interactor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr17:85,098,837...85,179,829
Ensembl chr17:85,098,550...85,179,792
|
|
G |
Ace |
angiotensin I converting enzyme |
|
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:25143335 |
RGD:25671447 |
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Acox3 |
acyl-CoA oxidase 3, pristanoyl |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr14:75,133,986...75,176,767
Ensembl chr14:75,094,676...75,176,205
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
|
|
G |
Actb |
actin, beta |
|
IEP ISO |
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:25231249 PMID:22563491 |
RGD:9587759 |
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Actn4 |
actinin alpha 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:84,182,783...84,251,867
Ensembl chr 1:84,182,788...84,251,847
|
|
G |
Actr3 |
actin related protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr13:36,800,739...36,843,837
Ensembl chr13:36,800,093...36,844,124
|
|
G |
Ada |
adenosine deaminase |
|
IEP |
protein:increased expression:liver |
RGD |
PMID:21161045 |
RGD:5128859 |
NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088
|
|
G |
Adam8 |
ADAM metallopeptidase domain 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24646716 |
|
NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20709802 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adipor2 |
adiponectin receptor 2 |
severity |
IEP |
associated with obesity, LPS;mRNA:decreased expression:liver (rat) |
RGD |
PMID:23838384 |
RGD:8695926 |
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
|
|
G |
Adora2b |
adenosine A2B receptor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:35292334 |
|
NCBI chr10:46,940,394...46,956,772
Ensembl chr10:46,940,384...46,956,772
|
|
G |
Agt |
angiotensinogen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29499335 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Ahr |
aryl hydrocarbon receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:21890736 PMID:34848246 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25743375 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Ak4 |
adenylate kinase 4 |
|
IEP |
protein:increased expression:liver (rat) |
RGD |
PMID:16538043 |
RGD:2301096 |
NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:32805337 PMID:29763686 |
RGD:27226688 |
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
|
|
G |
Alb |
albumin |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18779383 PMID:22310181 PMID:27567545 |
RGD:14694844 |
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh1l2 |
aldehyde dehydrogenase 1 family, member L2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 7:20,254,196...20,305,793
Ensembl chr 7:20,254,233...20,305,776
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
severity susceptibility |
IEP ISO |
protein:increased expression:liver DNA:deletion:exon 3 (mouse) |
RGD |
PMID:21138988 PMID:30121625 PMID:24492981 |
RGD:7241599, RGD:15036810, RGD:14975148 |
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Aldh9a1 |
aldehyde dehydrogenase 9 family, member A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr13:79,505,738...79,522,539
Ensembl chr13:79,505,695...79,540,568
|
|
G |
Aldob |
aldolase, fructose-bisphosphate B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16115720 |
|
NCBI chr 5:63,889,045...63,902,086
Ensembl chr 5:63,889,046...63,902,116
|
|
G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18779383 |
|
NCBI chr 5:76,568,094...76,578,416
Ensembl chr 5:76,568,094...76,578,331
|
|
G |
Anxa2 |
annexin A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
|
|
G |
Anxa6 |
annexin A6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr10:39,101,395...39,156,483
Ensembl chr10:39,097,109...39,156,433
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
Apoh |
apolipoprotein H |
|
IEP ISO |
mRNA:increased expression:plasma: CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16099942 PMID:23288050 |
RGD:10054107 |
NCBI chr10:93,342,435...93,356,334
Ensembl chr10:93,310,977...93,356,329
|
|
G |
Arg1 |
arginase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22872058 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20935161 |
|
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
|
|
G |
Atg5 |
autophagy related 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22491424 |
|
NCBI chr20:47,798,222...47,889,216
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Atoh8 |
atonal bHLH transcription factor 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 4:104,259,992...104,292,168
Ensembl chr 4:104,259,992...104,292,168
|
|
G |
Atp6v1d |
ATPase H+ transporting V1 subunit D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 6:97,656,725...97,672,211
Ensembl chr 6:97,656,576...97,672,303
|
|
G |
Bad |
BCL2-associated agonist of cell death |
treatment |
IDA |
|
RGD |
PMID:25447754 |
RGD:10053709 |
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17906064 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bdh1 |
3-hydroxybutyrate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr11:69,302,534...69,343,173
Ensembl chr11:69,302,534...69,337,671
|
|
G |
Bdkrb2 |
bradykinin receptor B2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30685357 |
|
NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497
|
|
G |
Blvrb |
biliverdin reductase B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
|
|
G |
Bpnt1 |
3'(2'), 5'-bisphosphate nucleotidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr13:96,865,634...96,893,506
Ensembl chr13:96,868,580...96,893,503
|
|
G |
Brd4 |
bromodomain containing 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 7:11,216,446...11,296,029
Ensembl chr 7:11,216,446...11,295,539
|
|
G |
Btd |
biotinidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15469856 |
|
NCBI chr16:6,863,068...6,894,345
Ensembl chr16:6,862,407...6,940,945
|
|
G |
C3 |
complement C3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
Cabp1 |
calcium binding protein 1 |
|
IEP |
protein:increased expression:liver |
RGD |
PMID:21138988 |
RGD:7241599 |
NCBI chr12:41,385,234...41,448,930
Ensembl chr12:41,378,897...41,448,927
|
|
G |
Cadps2 |
calcium dependent secretion activator 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr 4:51,780,415...52,309,641
Ensembl chr 4:51,781,053...52,309,829
|
|
G |
Canx |
calnexin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr10:34,623,865...34,656,866
Ensembl chr10:34,625,191...34,656,821
|
|
G |
Cap1 |
cyclase associated actin cytoskeleton regulatory protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 5:135,142,108...135,168,885
Ensembl chr 5:135,142,112...135,168,769
|
|
G |
Car3 |
carbonic anhydrase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 PMID:25231249 |
|
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
|
|
G |
Casp8 |
caspase 8 |
treatment |
IEP |
|
RGD |
PMID:25447754 |
RGD:10053709 |
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Cast |
calpastatin |
|
IEP |
|
RGD |
PMID:16871587 |
RGD:5683869 |
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
|
|
G |
Cat |
catalase |
|
ISO IEP |
CTD Direct Evidence: marker/mechanism protein:decreased expression:liver |
CTD RGD |
PMID:20623750 PMID:25231249 PMID:21138988 |
RGD:7241599 |
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccdc80 |
coiled-coil domain containing 80 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr11:55,685,165...55,718,827
Ensembl chr11:55,685,872...55,719,137
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20623750 PMID:21813474 PMID:30663942 |
RGD:14995466, RGD:14995458 |
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
susceptibility |
ISO |
acetaminophen |
RGD |
PMID:24770590 |
RGD:14401733 |
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
|
|
G |
Cct3 |
chaperonin containing TCP1 subunit 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 2:173,765,792...173,790,353
Ensembl chr 2:173,765,698...173,790,757
|
|
G |
Cct5 |
chaperonin containing TCP1 subunit 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 2:82,591,750...82,602,903
Ensembl chr 2:82,590,630...82,602,930
|
|
G |
Cdc25b |
cell division cycle 25B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 3:118,407,127...118,417,272
Ensembl chr 3:118,407,128...118,417,272
|
|
G |
Cds1 |
CDP-diacylglycerol synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr14:7,820,328...7,882,943
Ensembl chr14:7,820,351...7,882,681
|
|
G |
Cela1 |
chymotrypsin like elastase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 7:131,773,161...131,786,300
Ensembl chr 7:131,742,002...131,786,285
|
|
G |
Cfap20 |
cilia and flagella associated protein 20 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr19:9,608,851...9,622,562
Ensembl chr19:9,608,859...9,622,558
|
|
G |
Cfh |
complement factor H |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
|
|
G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20197374 |
|
NCBI chr17:60,005,137...60,467,250
Ensembl chr17:60,005,202...60,467,278
|
|
G |
Ckb |
creatine kinase B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
|
|
G |
Clu |
clusterin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Col14a1 |
collagen type XIV alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 7:86,722,093...86,937,215
Ensembl chr 7:86,722,094...86,937,214
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16679477 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Comt |
catechol-O-methyltransferase |
|
IEP |
protein:decreased expression:liver |
RGD |
PMID:21138988 |
RGD:7241599 |
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Coq9 |
coenzyme Q9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr19:10,166,948...10,179,976
Ensembl chr19:10,166,951...10,179,949
|
|
G |
Cp |
ceruloplasmin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
|
|
G |
Cpb2 |
carboxypeptidase B2 |
|
IEP |
mRNA,protein:increased expression,increased activity:liver,plasma |
RGD |
PMID:19386599 |
RGD:7243112 |
NCBI chr15:50,557,722...50,606,569
Ensembl chr15:50,557,717...50,606,556
|
|
G |
Cps1 |
carbamoyl-phosphate synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033
|
|
G |
Crp |
C-reactive protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr13:85,131,635...85,175,179
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Csf3 |
colony stimulating factor 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20005281 |
|
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:19679878 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Ctse |
cathepsin E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr13:43,091,954...43,114,509
Ensembl chr13:43,092,128...43,114,502
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16118408 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11739529 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16118408 |
|
NCBI chr14:17,270,146...17,289,458
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33814510 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28762043 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33814510 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp27b1 |
cytochrome P450, family 27, subfamily b, polypeptide 1 |
|
ISO |
mRNA, protein:decreased expression:kidney (mouse) |
RGD |
PMID:26476181 |
RGD:25671412 |
NCBI chr 7:62,869,340...62,876,242
Ensembl chr 7:62,871,297...62,876,241
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28762043 PMID:33814510 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
|
|
G |
Cyp2c6v1 |
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12963435 PMID:28762043 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
ISO |
DNA:hypermethylation:promoter |
RGD |
PMID:27490558 |
RGD:14700879 |
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism DNA:hypermethylation:promoter associated with Endotoxemia |
CTD RGD |
PMID:12668988 PMID:16770646 PMID:21741958 PMID:28762043 PMID:27960551 PMID:27490558 PMID:27324775 PMID:29404441 PMID:25681370 More...
|
RGD:14700901, RGD:14700879, RGD:14700878, RGD:14700873, RGD:14700872 |
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28762043 |
|
NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030
|
|
G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 5:129,097,571...129,115,488
Ensembl chr 5:129,097,926...129,115,463
|
|
G |
Cyp8b1 |
cytochrome P450 family 8 subfamily B member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25448281 |
|
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
|
|
G |
Dbt |
dihydrolipoamide branched chain transacylase E2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 2:204,481,744...204,510,612
Ensembl chr 2:204,481,737...204,510,609
|
|
G |
Ddb1 |
damage-specific DNA binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:207,252,890...207,278,685
Ensembl chr 1:207,252,890...207,278,676
|
|
G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17984051 |
|
NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428
|
|
G |
Dhfr |
dihydrofolate reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19648163 |
|
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
|
|
G |
Dhrs7 |
dehydrogenase/reductase 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 6:91,332,259...91,347,856
Ensembl chr 6:91,251,323...91,347,892
|
|
G |
Dlat |
dihydrolipoamide S-acetyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 8:50,979,151...51,004,435
Ensembl chr 8:50,978,051...51,004,479
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:61,269,913...61,275,063
|
|
G |
Dnajc12 |
DnaJ heat shock protein family (Hsp40) member C12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr20:25,246,744...25,267,508
Ensembl chr20:25,223,144...25,267,521
|
|
G |
Dsc2 |
desmocollin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr18:11,450,392...11,482,476
Ensembl chr18:11,450,390...11,482,392
|
|
G |
E2f1 |
E2F transcription factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30515189 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
Echdc1 |
ethylmalonyl-CoA decarboxylase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 1:28,476,354...28,507,173
Ensembl chr 1:28,476,200...28,507,319
|
|
G |
Echs1 |
enoyl-CoA hydratase, short chain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:194,895,036...194,903,863
Ensembl chr 1:194,895,036...194,903,884
|
|
G |
Edem1 |
ER degradation enhancing alpha-mannosidase like protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 4:141,797,631...141,829,717
Ensembl chr 4:141,797,701...141,829,717
|
|
G |
Eif2ak1 |
eukaryotic translation initiation factor 2 alpha kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25411909 |
|
NCBI chr12:10,710,771...10,744,597
Ensembl chr12:10,705,874...10,744,573
|
|
G |
Eif4ebp2 |
eukaryotic translation initiation factor 4E binding protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr20:29,379,444...29,400,131
Ensembl chr20:29,382,668...29,399,946
|
|
G |
Endog |
endonuclease G |
|
IEP |
protein:decreased expression:mitochondrion: |
RGD |
PMID:22509279 |
RGD:9685364 |
NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932
|
|
G |
Eng |
endoglin |
|
IEP |
protein:increased expression:liver (rat) |
RGD |
PMID:21146604 |
RGD:7257529 |
NCBI chr 3:15,934,566...15,972,618
Ensembl chr 3:15,934,518...15,973,230
|
|
G |
Eno1 |
enolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 PMID:25231249 |
|
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
|
|
G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
IEP |
protein:increased activity:serum: |
RGD |
PMID:17850827 |
RGD:9685426 |
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr13:92,714,315...92,744,124
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Erlec1 |
endoplasmic reticulum lectin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr14:104,655,745...104,693,508
Ensembl chr14:104,655,673...104,693,480
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30538632 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
F13a1 |
coagulation factor XIII A1 chain |
|
ISO |
|
RGD |
PMID:22019897 |
RGD:11041813 |
NCBI chr17:27,815,723...27,992,494
Ensembl chr17:27,815,702...27,992,700
|
|
G |
F2rl3 |
F2R like thrombin or trypsin receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20974703 |
|
NCBI chr16:17,117,441...17,119,434
Ensembl chr16:17,117,441...17,119,472
|
|
G |
F3 |
coagulation factor III, tissue factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22407844 |
|
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
Fadd |
Fas associated via death domain |
treatment |
IEP |
|
RGD |
PMID:26062544 PMID:25447754 |
RGD:11341803, RGD:10053709 |
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Fads1 |
fatty acid desaturase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 1:206,827,724...206,842,734
Ensembl chr 1:206,827,765...206,842,734
|
|
G |
Fads2 |
fatty acid desaturase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789
|
|
G |
Fas |
Fas cell surface death receptor |
|
IEP |
protein:increased expression:liver (rat) |
RGD |
PMID:16831245 |
RGD:8662853 |
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fasn |
fatty acid synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fcmr |
Fc mu receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr13:42,337,363...42,351,706
Ensembl chr13:42,337,414...42,351,653
|
|
G |
Fga |
fibrinogen alpha chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20974703 |
|
NCBI chr 2:168,365,364...168,381,533
Ensembl chr 2:168,374,120...168,381,528
|
|
G |
Fgf21 |
fibroblast growth factor 21 |
severity |
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:29883717 |
RGD:15045603 |
NCBI chr 1:96,083,495...96,084,738
Ensembl chr 1:96,083,441...96,090,454
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21135413 |
|
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Fmo3 |
flavin containing dimethylaniline monoxygenase 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:24973094 |
|
NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028
|
|
G |
Ftl1 |
ferritin light chain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:95,936,390...95,938,234
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
|
ISO |
mRNA:decreased expression:liver (mouse) |
RGD |
PMID:28189721 |
RGD:14695531 |
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
treatment |
IEP |
|
RGD |
PMID:21864513 |
RGD:10449168 |
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Ganab |
glucosidase II alpha subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:205,793,810...205,813,701
Ensembl chr 1:205,793,895...205,813,695
|
|
G |
Gc |
GC, vitamin D binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
IMP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:19481141 PMID:17573345 |
RGD:10402383 |
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gda |
guanine deaminase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:218,903,045...218,982,360
Ensembl chr 1:218,906,815...218,982,416
|
|
G |
Gdi1 |
GDP dissociation inhibitor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr X:152,087,611...152,094,274
Ensembl chr X:152,087,444...152,094,272
|
|
G |
Gfer |
growth factor, augmenter of liver regeneration |
treatment |
ISO IDA |
|
RGD |
PMID:22033404 PMID:15968720 |
RGD:9685722, RGD:9685727 |
NCBI chr10:13,718,489...13,721,782
Ensembl chr10:13,718,489...13,720,869
|
|
G |
Ggh |
gamma-glutamyl hydrolase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21219404 |
|
NCBI chr 5:33,529,880...33,552,790
Ensembl chr 5:33,529,880...33,552,787
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
IEP |
|
RGD |
PMID:10934156 |
RGD:14701049 |
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
|
|
G |
Glud1 |
glutamate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33483742 |
|
NCBI chr16:9,640,312...9,673,961
Ensembl chr16:9,640,312...9,673,957
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 7:130,842,526...130,851,530
Ensembl chr 7:130,844,138...130,851,529
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism protein:increased expression, activity:serum: |
CTD RGD |
PMID:145039 PMID:19481104 PMID:19085960 PMID:19085960 PMID:27293452 PMID:21772750 PMID:28487901 More...
|
RGD:14975249, RGD:14975249, RGD:14975168, RGD:14975166, RGD:14975162 |
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpt2 |
glutamic--pyruvic transaminase 2 |
|
IEP ISO |
protein:increased expression, activity:serum: |
RGD |
PMID:19085960 PMID:19085960 |
RGD:14975249, RGD:14975249 |
NCBI chr19:21,526,800...21,561,314
Ensembl chr19:21,517,621...21,560,610
|
|
G |
Grk4 |
G protein-coupled receptor kinase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr14:75,998,554...76,080,808
Ensembl chr14:76,006,218...76,080,693
|
|
G |
Gsn |
gelsolin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
|
|
G |
Gsr |
glutathione-disulfide reductase |
treatment |
IEP ISO |
mRNA, protein:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:25226513 PMID:28069987 PMID:23554813 PMID:24154663 |
RGD:7257532, RGD:10401878 |
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
no_association |
ISO IEP |
CTD Direct Evidence: marker/mechanism protein:increased expression:liver |
CTD RGD |
PMID:17465707 PMID:18666253 PMID:25501156 PMID:24465778 PMID:24903797 PMID:29523098 PMID:21138988 More...
|
RGD:14700970, RGD:14700959, RGD:14700941, RGD:14700937, RGD:7241599 |
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gstm4 |
glutathione S-transferase mu 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 2:195,667,940...195,685,315
Ensembl chr 2:195,680,004...195,685,323
|
|
G |
Gstm5 |
glutathione S-transferase, mu 5 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25743375 |
|
NCBI chr 2:195,531,627...195,534,562
Ensembl chr 2:195,531,495...195,534,553
|
|
G |
Gsto1 |
glutathione S-transferase omega 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:246,721,089...246,731,228
Ensembl chr 1:246,721,221...246,731,468
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 PMID:25226513 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18397238 PMID:18666253 PMID:25226513 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
H19 |
H19 imprinted maternally expressed transcript |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30515189 |
|
NCBI chr 1:197,730,698...197,733,374
Ensembl chr 1:197,730,698...197,733,134
|
|
G |
H2ax |
H2A.X variant histone |
treatment |
IDA |
|
RGD |
PMID:23265463 |
RGD:8693741 |
NCBI chr 8:44,671,927...44,673,257
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Hacl1 |
2-hydroxyacyl-CoA lyase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr16:6,826,881...6,863,027
Ensembl chr16:6,824,906...6,863,027
|
|
G |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
|
IEP |
mRNA:increased expression:hepatocyte |
RGD |
PMID:24373749 |
RGD:11041724 |
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
|
|
G |
Hao2 |
hydroxyacid oxidase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 2:186,200,137...186,232,997
Ensembl chr 2:186,200,504...186,224,425
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
|
|
G |
Hba-a1 |
hemoglobin alpha, adult chain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr10:15,337,265...15,338,121
Ensembl chr10:15,307,815...15,338,392
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:19783637 PMID:29091898 |
RGD:15090820 |
NCBI chr12:5,973,062...5,978,565
Ensembl chr12:5,901,586...5,978,565
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
IEP ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD RGD |
PMID:18227147 PMID:22688006 PMID:22886620 PMID:29091898 |
RGD:10762620, RGD:15090820 |
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hpd |
4-hydroxyphenylpyruvate dioxygenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 PMID:22872058 |
|
NCBI chr12:33,381,397...33,392,750
Ensembl chr12:33,381,231...33,392,766
|
|
G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr X:132,736,175...132,768,149
Ensembl chr X:132,736,096...132,768,154
|
|
G |
Hpx |
hemopexin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr 1:159,932,819...159,940,327
Ensembl chr 1:159,932,755...159,940,328
|
|
G |
Hrh2 |
histamine receptor H 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22926047 |
|
NCBI chr17:10,368,355...10,407,791
Ensembl chr17:10,368,298...10,407,631
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
|
IEP |
protein:altered localization:liver (rat) |
RGD |
PMID:12376827 |
RGD:10059389 |
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
treatment |
IEP |
|
RGD |
PMID:29091898 |
RGD:15090820 |
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
severity |
ISO |
|
RGD |
PMID:31121248 |
RGD:14985250 |
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
|
|
G |
Ido2 |
indoleamine 2,3-dioxygenase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32289347 |
|
NCBI chr16:67,459,158...67,498,052
Ensembl chr16:67,459,190...67,496,324
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:12153990 PMID:21245496 PMID:30013034 |
RGD:14975100 |
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igf1 |
insulin-like growth factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23639586 PMID:25226513 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Il11 |
interleukin 11 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11421492 |
|
NCBI chr 1:69,069,829...69,076,129
Ensembl chr 1:69,068,137...69,076,129
|
|
G |
Il17a |
interleukin 17A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19633216 PMID:24949944 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il18 |
interleukin 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19164858 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:8218930 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
treatment |
IDA IEP ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD RGD |
PMID:19164858 PMID:28138970 PMID:23102243 PMID:29091898 PMID:31342809 PMID:31077717 PMID:29278859 More...
|
RGD:7204421, RGD:15090820, RGD:15036799, RGD:14975281, RGD:13793380 |
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r2 |
interleukin 1 receptor type 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17984051 |
|
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
|
|
G |
Il22 |
interleukin 22 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15122762 PMID:16212920 PMID:23375450 |
|
NCBI chr 7:53,801,206...53,805,673
Ensembl chr 7:53,801,206...53,806,186
|
|
G |
Il4 |
interleukin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:21094227 PMID:21735453 PMID:22107450 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il6 |
interleukin 6 |
treatment |
ISO IEP |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:7532385 PMID:15763341 PMID:29091898 |
RGD:15090820 |
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Immt |
inner membrane mitochondrial protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 4:103,880,482...103,919,116
Ensembl chr 4:103,880,459...103,919,109
|
|
G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr X:151,768,621...151,778,521
Ensembl chr X:151,768,777...151,778,521
|
|
G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
|
|
G |
Jund |
JunD proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30515189 |
|
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
|
ISO |
|
RGD |
PMID:18417483 |
RGD:6893370 |
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Kitlg |
KIT ligand |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12594235 |
|
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
|
|
G |
Kng2 |
kininogen 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20362651 PMID:30685357 |
|
NCBI chr11:77,913,876...77,936,247
Ensembl chr11:77,909,612...78,002,971
|
|
G |
Krt18 |
keratin 18 |
|
ISO |
mRNA, protein:increased expression:liver (mouse) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:19783637 PMID:33483742 PMID:17340120 |
RGD:18337498 |
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
|
|
G |
Krt8 |
keratin 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
|
|
G |
Lap3 |
leucine aminopeptidase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr14:65,608,375...65,627,359
Ensembl chr14:65,608,376...65,627,359
|
|
G |
Lbp |
lipopolysaccharide binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
|
|
G |
Lcn2 |
lipocalin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20362651 PMID:20623750 |
|
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
|
|
G |
Lgals3 |
galectin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22461450 |
|
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
|
|
G |
|